Duloxetine Hydrochloride
Who holds supplier records for Duloxetine Hydrochloride? 37 organisations hold a current record for Duloxetine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 27 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (22), China (5), Spain (2), Taiwan (1) and 4 other countries (4); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Duloxetine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/duloxetine-hydrochloride
Reading the evidence
- 37 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
22 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 21 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (37)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Duloxetine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 23702, 30390 · latest filing Mar 2016
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 21767, 33633 · latest filing Mar 2019
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 28961, 21524 · latest filing Mar 2015
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 35805, 20996 · latest filing Mar 2021
- SHANKUS PHARMA PRIVATE LTDIndiaCEPActive DMF 43451, 43220 · latest filing Jan 2026
- Alkem Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 24685 · latest filing Mar 2011
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 25280 · latest filing Sept 2011
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 40282 · latest filing Jul 2024
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 25890 · latest filing Mar 2012
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 25036 · latest filing Jun 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 21478 · latest filing Mar 2008
- MOEHS IBERICA SLSpainCEPActive DMF 36834 · latest filing Mar 2022
- SCI PHARMTECH INCTaiwanCEPActive DMF 24939 · latest filing May 2011
- SHODHANA LABORATORIES LTDIndiaCEPActive DMF 28398, 40165 · latest filing Jul 2024
- TAPI NL BVNetherlandsCEPActive DMF 21827 · latest filing Jul 2008
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 23051 · latest filing Mar 2009
- Zhejiang Liaoyuan Pharmaceutical Co., Ltd.ChinaCEPActive DMF 29500 · latest filing Jun 2015
- Zhejiang Yongtai Pharmaceutical Co., Ltd.ChinaCEPActive DMF 30174 · latest filing Mar 2016
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 28390 · latest filing Jun 2014
- Ajanta Pharma LimitedIndiaActive DMF 37458 · latest filing Sept 2022
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 20296 · latest filing Feb 2007
- HEC PHARM COChina Company GMP cert on recordActive DMF 30172 · latest filing Feb 2016
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 21635 · latest filing Jun 2008
- R.L.FINE CHEM PRIVATE LIMITEDIndiaActive DMF 33072 · latest filing Aug 2018
- Shanghai Wonder Pharmaceutical Co., LtdChinaActive DMF 34678 · latest filing Mar 2020
- SIGNA SA DE CVActive DMF 21833 · latest filing Jul 2008
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21752 · latest filing Jul 2008
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 21485 · latest filing Mar 2008
- Wockhardt LimitedIndia Company GMP cert on recordActive DMF 21604 · latest filing Apr 2008
- HungaryCEP Company GMP cert on record
- ESTEVE QUIMICA SACEP Company GMP cert on recordInactive DMF 24659 · latest filing Feb 2011
- IndiaCEP Company GMP cert on record
- NOSCH LABS PRIVATE LTDCEP Company GMP cert on recordInactive DMF 26789 · latest filing Jan 2013
- IndiaCEP
- SlovakiaCEP Company GMP cert on record
- SpainCEP
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (27)
Certificates of Suitability on the EDQM register for Duloxetine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 40 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2026-287 - Rev 00 Duloxetine hydrochloride, Process-II | Oct 2026 | — |
| SHANKUS PHARMA PRIVATE LIMITED Mehsana | IN | CEP 2025-008 - Rev 00 Duloxetine hydrochloride | Sept 2026 | — |
| SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri | IN | CEP 2026-269 - Rev 00 Duloxetine hydrochloride, Alternate Manufacturing Process | Sept 2026 | — |
| ALKEM LABORATORIES LIMITED Mumbai | IN | CEP 2024-139 - Rev 01 Duloxetine hydrochloride | Sept 2026 | — |
| NOSCH LABS PRIVATE LIMITED Hyderabad | IN | CEP 2012-247 - Rev 02 Duloxetine hydrochloride | Jul 2026 | — |
| MOEHS IBERICA S.L. Rubi | ES | CEP 2026-122 - Rev 00 Duloxetine hydrochloride, M02 milled, M02 micronised | Jun 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2012-305 - Rev 04 Duloxetine hydrochloride | Jun 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2014-012 - Rev 02 Duloxetine hydrochloride | Mar 2026 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2024-316 - Rev 00 Duloxetine hydrochloride | Oct 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2012-203 - Rev 04 Duloxetine hydrochloride | Sept 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2024-273 - Rev 01 Duloxetine hydrochloride, Process-K | Jul 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2012-311 - Rev 04 Duloxetine hydrochloride | Jan 2025 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | CEP 2023-144 - Rev 00 Duloxetine hydrochloride | Dec 2024 | Inspected Nov 2025 Hungary |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2023-132 - Rev 00 Duloxetine hydrochloride, Micronised, Form-A | Dec 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2012-368 - Rev 01 Duloxetine hydrochloride | Jul 2024 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R1-CEP 2012-118 - Rev 03 Duloxetine hydrochloride | Jul 2023 | — |
| R L FINE CHEM PVT. LTD. Gowribidanur | IN | R0-CEP 2020-313 - Rev 00 Duloxetine hydrochloride | Oct 2022 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2012-220 - Rev 02 Duloxetine hydrochloride | Oct 2022 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R0-CEP 2021-003 - Rev 00 Duloxetine hydrochloride, Process B | Oct 2022 | — |
| SCI PHARMTECH, INC. Taoyuan City | TW | R1-CEP 2012-217 - Rev 01 Duloxetine hydrochloride | Sept 2022 | — |
| ZHEJIANG YONGTAI PHARMACEUTICAL CO., LTD. Duqiao | CN | R1-CEP 2016-142 - Rev 00 Duloxetine hydrochloride | Mar 2022 | — |
| LUPIN LIMITED Mumbai | IN | R1-CEP 2015-144 - Rev 00 Duloxetine hydrochloride | Mar 2022 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | R1-CEP 2015-246 - Rev 00 Duloxetine hydrochloride | Mar 2022 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2015-166 - Rev 00 Duloxetine hydrochloride | Oct 2021 | — |
| SANECA PHARMACEUTICALS A.S. Hlohovec | SK | R1-CEP 2014-297 - Rev 00 Duloxetine hydrochloride | Aug 2021 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | R1-CEP 2013-016 - Rev 02 Duloxetine hydrochloride | Jul 2021 | — |
| ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town | CN | R1-CEP 2014-239 - Rev 00 Duloxetine hydrochloride | Aug 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Duloxetine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- India · Inactive DMF 29540 · filed Jul 2015
- JIANGSU HANSOH PHARMACEUTICAL CO LTDInactive DMF 25625 · filed Dec 2011
- India · Inactive DMF 19631, 24274 · filed Oct 2010
- Italy · Inactive DMF 23133 · filed Sept 2009
- India · Inactive DMF 22867 · filed Jun 2009
- ZHEJIANG HISOAR PHARMACEUTICAL CO LTD CHUANNAN BRANCHInactive DMF 22086 · filed Sept 2008
- RANBAXY LABORATORIES LTDInactive DMF 21838 · filed Jul 2008
- CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTDInactive DMF 21801 · filed Jul 2008
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 21385 · filed Feb 2008
- Italy · Inactive DMF 19974 · filed Nov 2006
- MATRIX LABORATORIES LTDInactive DMF 19860 · filed Oct 2006
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Duloxetine hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the treatment of major depressive disorder and generalized anxiety disorder. It is also indicated for managing neuropathic pain associated with diabetic peripheral neuropathy and fibromyalgia.
Chemical identity
- IUPAC name
- (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride
- Canonical SMILES
- CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl
- InChIKey
- BFFSMCNJSOPUAY-LMOVPXPDSA-N
- Synonyms
- Cymbalta API, (s)-(+)-duloxetine hydrochloride, ariclaim, cymbalta, duloxetine boehringer ingelheim, duloxetine mylan, duloxetine (as hydrochloride), duloxetine hcl, ly-248686 hcl, ly248686 hcl, nsc-759112, xeristar
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
- Mechanism of action
- Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Duloxetine Hydrochloride?
37 organisations hold an active US FDA Type II Drug Master File or a CEP for Duloxetine Hydrochloride: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Lupin Limited (India), MSN Laboratories Private Limited (India), SHANKUS PHARMA PRIVATE LTD (India), Alkem Laboratories Limited (India), Hetero Drugs Limited (India) and Ipca Laboratories Limited (India), and 29 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Duloxetine Hydrochloride Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 23702, 30390), APITORIA PHARMA PRIVATE LTD (DMF 21767, 33633), Lupin Limited (DMF 28961, 21524), MSN Laboratories Private Limited (DMF 35805, 20996), SHANKUS PHARMA PRIVATE LTD (DMF 43451, 43220), Alkem Laboratories Limited (DMF 24685), Hetero Drugs Limited (DMF 25280) and Ipca Laboratories Limited (DMF 40282) and 21 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Duloxetine Hydrochloride records mean?
11 organisations have only inactive Type II DMFs for Duloxetine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Duloxetine Hydrochloride have a European Certificate of Suitability?
Yes. 27 organisations hold a valid CEP for Duloxetine Hydrochloride on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), SHANKUS PHARMA PRIVATE LIMITED Mehsana (IN), SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri (IN), ALKEM LABORATORIES LIMITED Mumbai (IN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN) and MOEHS IBERICA S.L. Rubi (ES) and 21 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Duloxetine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Duloxetine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.